Karim A. Hosny

Kasr El Aini St
Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma.

OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma.

Journal: BMC gastroenterology

Published: June 09, 2024

Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.

Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.

Journal: Life sciences

Published: June 02, 2022

Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.

Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.

Journal: Pathogens and global health

Published: September 08, 2021

Resuming post living donor liver transplantation in the COVID-19 pandemic: real-life experience, single-center experience.

Resuming post living donor liver transplantation in the COVID-19 pandemic: real-life experience, single-center experience.

Journal: Egyptian liver journal

Published: August 27, 2021

Management of early hepatic artery thrombosis following living-donor liver transplantation: feasibility, efficacy and potential risks of endovascular therapy in the first 48 hours post-transplant-a retrospective cohort study.

Management of early hepatic artery thrombosis following living-donor liver transplantation: feasibility, efficacy and potential risks of endovascular therapy in the first 48 hours post-transplant-a retrospective cohort study.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: September 06, 2020

Effect of Portal Venous Pressure on Liver Function of Donors in Living Donor Liver Transplantation.

Effect of Portal Venous Pressure on Liver Function of Donors in Living Donor Liver Transplantation.

Journal: Annals of transplantation

Published: July 06, 2019

Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma.

Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma.

Journal: Frontiers in physiology

Published: September 10, 2018

Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center.

Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center.

Journal: Annals of Saudi medicine

Published: June 01, 2018

Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.

Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Published: March 18, 2017

miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.

miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.

Journal: Journal of clinical and translational hepatology

Published: August 24, 2016

Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.

Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.

Journal: Growth factors (Chur, Switzerland)

Published: April 30, 2016

Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.

Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma.

Journal: World journal of hepatology

Published: March 06, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026